site.btaARPharM Director: Bulgarians Have Access To Third of New Therapies Authorised in Europe
Bulgarian patients have access to a third of the new therapies authorised in Europe, said the Director of the Association of the Research-Based Pharmaceutical Manufacturers in Bulgaria (ARPharM), Deyan Denev, on Tuesday, during a forum dedicated to
/NF/
news.modal.header
news.modal.text